Palliative care for patients with amyotrophic lateral sclerosis: "Prepare for the worst and hope for the best"

JAMA

Volumn 298, Issue 2, 2007, Pages 207-216

  Mitsumoto, Hiroshi ^a   Rabkin, Judith G ^a  

^a Neurological Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CAREGIVER; CASE REPORT; CLINICAL PRACTICE; COGNITIVE DEFECT; DEFECATION URGENCY; DRUG COST; DYSPNEA; ELECTROMYOGRAPHY; ENTERIC FEEDING; FAMILY ATTITUDE; HEALTH CARE COST; HUMAN; MALE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NUTRITION; PALLIATIVE THERAPY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRACHEOSTOMY; URINARY URGENCY; ARTICLE; DOCTOR PATIENT RELATION; ECONOMICS; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

AMYOTROPHIC LATERAL SCLEROSIS; CAREGIVERS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT CARE TEAM; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS;

EID: 34447281327     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.2.207     Document Type: Review

References (92)

1. Mitsumoto H, Bromberg M, Johnston W, et al. Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(3):145-154.
2. Institute of Medicine. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997:31.
3. Rowland LP, Mitsumoto H, De Vivo D. Hereditary and acquired motor neuron diseases. In: Rowland LP, ed. Merritt's Neurology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:861-870.
4. Mitsumoto H. The clinical features and prognosis in ALS. In: Mitsumoto H, Munsat T, eds. Amyotrophic Lateral Sclerosis: A Guide for Patients and Families. 2nd ed. New York, NY: Demos; 2001:27.
5. McGuire V, Nelson LM. Epidemiology of ALS. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:17-41.
6. Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep. 2006;6(1):37-46.
7. Nagai M, Re DB, Nagata T, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci. 2007;10(5):615-622.
8. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723-749.
9. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7(9):710-723.
10. Rowland LP, Schneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688-1700.
11. Wood JD, Beaujeux TP, Shaw PJ. Protein aggregation in motor neurone disorders. Neuropathol Appl Neurobiol. 2003;29(6):529-545.
12. Miller RG, Anderson F, Gowda N, et al. The ALS Patient CARE Program - North American CARE database. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:633-648.
13. Zoccolella S, Beghi E, Guerra V, et al. Prognosis of amyotrophic lateral sclerosis in southern Italy: results from a population-based registry SLAP. Amyotroph Lateral Scler. 2006;7(suppl 1):100.
14. Murray B. Natural history and prognosis in amyotrophic lateral sclerosis. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:227-255.
15. Hayashi H, Oppenheimer A. ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications. Neurology. 2003;61(1):135-137.
16. Cwik V. ALS Clinical Motor Signs and Symptoms. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:99-115.
17. Li T-M, Alberman E, Swash M. Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1990;53(12):1043-1045.
18. Shoesmith CL, Rowe A, Strong MJ, Findlater K. Prognostic factors in amyotrophic lateral sclerosis within southwestern Ontario, Canada. Amyotroph Lateral Scler. 2006;7(suppl 1):101.
19. Del Bene ML, Albert S, Brandis M, Mitsumoto H. Validation of vital capacity as the primary tool for predicting patient timing for formal palliative care intervention. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(suppl 1):64-65.
20. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2007;(1):CD001447.
21. Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(8)(suppl 5):S26-S30.
22. Brooks BR, Miller R, Swash M, Munsat T; World Federation of Neurology Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
23. Srinivasan J, Scala S, Jones HR, Saleh F, Russell JA. Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(3):359-360.
24. Yoshor D, Klugh A, Appel SH, Haverkamp LJ. Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery. 2005;57(5):984-989.
25. McCluskey L, Casarett D, Siderowf A. Breaking the news: a survey of ALS patients and their caregivers. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(3):131-135.
26. Girgis A, Sanson-Fisher RW. Breaking bad news: Consensus guidelines for medical practitioners. J Clin Oncol. 1995;13(9):2449-2456.
27. Chad DA. Classification, diagnosis and presentation of diagnosis in ALS. In: Mitsumoto H, Przedbokski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:201-225.
28. Larson AM, Curtis JR. Integrating palliative care for liver transplant candidates. JAMA. 2006;295(18):2168-2175.
29. Lamont EB, Christakis NA. Complexities in prognostication in advanced cancer. JAMA. 2003;290(1):98-105.
30. Silani V, Borasio G. Honesty and hope: announcement of diagnosis in ALS. Neurology. 1999;53(8)(suppl 5):S37-S39.
31. Mitsumoto H, Borasio G, Genge A, et al. The multidisciplinary care clinic: the principles and an international perspective. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:605-631.
32. Miller RG, Scholtz D, Moore DH, et al. Treatment of patients with ALS in the community: New insights from the web-based ALS patient care database. Amyotroph Lateral Scler. 2006;7(suppl 1):56.
33. Van den Berg JP, Kalmijn S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65(8):1264-1267.
34. Miller RG, Anderson FA Jr, Bradley WG, et al; ALS C.A.R.E. Study Group. The ALS patient care database: goals, design, and early results. Neurology. 2000;54(1):53-57.
35. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003;74(9):1258-1261.
36. Krivikas LS, Bello-Haas V, Danforth S, Carter G. Rehabilitation. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:691-720.
37. Stillman MJ. Palliative care: the management of advanced disease. In: Mitsumoto H, Munsat TL, eds. Amytrophic Lateral Sclerosis: A Guide for Patients and Families. 2nd ed. New York, NY: Demos; 2001:359-372.
38. Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(2):235-237.
39. Jackson CE, Rosenfeld J. Symptomatic Pharmacotherapy: bulbar and constitutional symptoms. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:649-664.
40. Ganzini L, Johnston W, McFarland B, Tolle S, Lee M. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med. 1998;339(14):967-973.
41. Rabkin JG, Albert SM, Del Bene M, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65(1):62-67.
42. Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006;11(6):1-7.
43. Krivickas LS, Shockley L, Mitsumoto H. Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci. 1997;152(suppl 1):S82-S89.
44. Gelinas D. Treating the symptoms of ALS. In: Mitsumoto H, Munsat T, eds. Amyotrophic Lateral Sclerosis: A guide for Patients and Families. 2nd ed. New York, NY: Demos; 2001:47-62.
45. Montgomery GK, Erickson LM. Neuropsychological perspectives in amyotrophic lateral sclerosis. Neurol Clin. 1987;5(1):61-81.
46. Ringholz GM, Appel S, Bradshaw M, Cooke N, Mosnick D, Schulz P. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586-590.
47. Lomen Hoerth C, Strong MJ. Frontotemporal dysfunction in amyotrophic lateral sclerosis. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis Group; 2006:117-141.
48. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59(7):1077-1079.
49. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
50. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65(11):1774-1777.
51. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059-1063.
52. Miller RG, Rosenberg JA, Gelinas DF, et al; ALS practice Parameters Task Force. Practice parameter: an evidence-based review. Neurology. 1999;52(7):1311-1323.
53. Albert SM, Murphy PL, Del Bene M, Rowland LP, Mitsumoto H. Incidence and predictors of PEG placement in ALS/MND. J Neurol Sci. 2001;191(1-2):115-120.
54. Mitsumoto H, Davidson M, Moore D, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):177-185.
55. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242(10):695-698.
56. Simpson EP, Gonzalez M, Rosenfield D, Pleitez M, Appel S. The use of maximal inspiratory pressure (MIP) as an indicator for early initiation of NIPPV in ALS patients. Amyotroph Lateral Scler. 2006;7(suppl 1):64.
57. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124 (pt 10):2000-2013.
58. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140-147.
59. Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology. 2006;66(8):1211-1217.
60. Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology. 2001;57(1):153-156.
61. Borasio GD, Gelinas DF, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol. 1998;245(suppl 2):S7-S12.
62. Rabow MW, Hauser J, Adams J. Supporting family caregivers at the end of life. JAMA. 2004;291(4):483-491.
63. Chiò A, Gauthier A, Calvo A, Ghiglione P, Mutani R. Caregiver burden and patients' perception of being a burden in ALS. Neurology. 2005;64(10):1780-1782.
64. Goldstein LH, Adamson M, Barby T, Down K, Leigh N. Attributions, strain and depression in carers of partners with MND: A preliminary investigation. J Neurol Sci. 2000;180(1-2):101-106.
65. Krivickas LS, Shockley L, Mitsumoto H. Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci. 1997;152(suppl 1):S82-S89.
66. Goldstein LH, Atkins L, Landau S, Brown R, Leigh P. Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychol Med. 2006;36(6):865-875.
67. Rabkin JG, Wagner G, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62(2):271-279.
68. Chen ML, Chu L, Chen HC. Impact of the cancer patients' quality of life on that of spouse caregivers. Support Care Cancer. 2004;12(7):469-475.
69. Nijboer C, Triemstra M, Tempelaar R, Sanderman R, van den Bos G. Determinants of caregiving experiences and mental health of partners of cancer patients. Cancer. 1999;86(4):577-588.
70. Rabkin JG, Albert SM, Tider T, et al. Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients. Amyotroph Lateral Scler. 2006;7(2):86-95.
71. Vachon ML. Burnout and symptoms of stress in staff working in palliative care. In: Chochinov H, Breitbart W, eds. Handbook of Psychiatry in Palliative Medicine. New York, NY: Oxford University Press; 303-319.
72. Sykes NP. Palliative care at the end of life. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2006:783-797.
73. Smyth A, Riedl M, Kimura R, Olick R, Siegler M. End of life decisions in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol Sci. 1997;152(suppl 1):S93-S96.
74. Neudert C, Oliver D, Wasner M, Borasio G. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612-616.
75. Hayashi H. The long-term communication strategy in patients with TPPV throughout the total course of ALS. Amyotroph Lateral Scler. 2006;7(suppl 1):25-26.
76. Moss AH, Casey P, Stocking CB, et al. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs and patient, family and physician attitudes. Neurology. 1993;43(2):438-443.
77. Moss AH, Oppenheimer EA, Casey P, et al. Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Chest. 1996;110(1):249-255.
78. Kaub-Wittemer D, Steinbuchel N, Wasner M, Laier-Groeneveld G, Borasio G. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26(4):890-896.
79. Albert SM, Murphy PL, Del Bene M, Rowland L. A prospective study of preferences and actual treatment choices in amyotrophic lateral sclerosis. Neurology. 1999;53(2):278-283.
80. Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061- 1066.
81. Patrick DL, Pearlman R, Starks H, Cain K, Cole W, Uhlman R. Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med. 1997;127(7):509-517.
82. Meier DE, Morrison RS. Autonomy reconsidered [editorial]. N Engl J Med. 2002;346(14):1087-1089.
83. Nakajima T. Individual ALS care in the Japanese "Nanbyo" care model: Comparison with palliative care approaches in achieving best quality of life. Amyotroph Lateral Scler. 2006;7(suppl 1):45.
84. Gelinas DF, O'Connor P, Miller R. Quality of life for ventilator-dependent patients and their caregivers. J Neurol Sci. 1998;160(suppl 1):S134-S136.
85. Lo B, Rubenfeld G. Palliative sedation in dying patients. JAMA. 2005;294(14):1810-1816.
86. Lynn J. Serving patients who may die soon and their families: the role of hospice and other services. JAMA. 2001;285(7):925-932.
87. Quill TE. Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room." JAMA. 2000;284(19):2502-2507.
88. Olney RK, Lomen-Hoarth C. Exit strategies in ALS: an influence of depression or despair? [editorial]. Neurology. 2005;65(1):9-10.
89. Albert SM, Rabkin J, Del Bene M, et al. Wish to die in end-stage ALS. Neurology. 2005;65(1):68-74.
90. Ganzini L, Johnston W. End-of-Life decision making. In: Mitsumoto H, Przedborski S, Gordon P, eds. Amyotrophic Lateral Sclerosis. New York, NY: Taylor & Francis; 2005:811-824.
91. Bascom PB, Tolle S. Responding to requests for physician-assisted suicide. JAMA. 2002;288(1):91-99.
92. Rabkin JG, Remien R, Wilson C. Good Doctors, Good Patients: Partners in HIV Treatment. New York, NY: NCM; 1995.